Pipeline — registered trials by phase
Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis
— · Aortic Valve Stenosis · Completed · est. 2013-04
TurboHawk™ Japan Trial in Patients With PAD
— · Peripheral Arterial Disease · Completed · est. 2015-09
AFFIX: Post-market Study of MaxTack™ Motorized Fixation Device in Subjects Undergoing Ventral Hernia Repair
— · Ventral Hernia · Active Not Recruiting · est. 2026-07-28
The SymCHro - Observational Registry Study for Symbotex™ Composite Mesh in Ventral Hernia Repair
— · Ventral Incisional Hernia · Completed · est. 2017-05-22
Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent
— · Coronary Artery Disease · Completed · est. 2010-05
Optimize RV Follow-up Selective Site Pacing Clinical Trial
— · Cardiac Pacing, Right Ventricular Pacing, Left Ventricular Ejection Fraction · Completed · est. 2011-04
APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias
— · Tachyarrhythmia · Completed · est. 2011-06
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study
— · Heart Failure · Active Not Recruiting · est. 2024-12-06
The VIRTUE Post Marketing Surveillance Registry
— · Aortic Dissection · Completed · est. 2012-10
Mapping for Acute Transvenous Phrenic Nerve Stimulation Study
— · Sleep Apnea · Completed · est. 2015-09
A Pivotal Study to Evaluate Guardian™ Connect CGM System Performance in China
— · Diabetes Mellitus · Completed · est. 2019-07-25
Left Ventricular MultiSpot Pacing for CRT (iSPOT)
— · Heart Failure · Completed · est. 2014-12
EASE MITRAL Expertise-based Assessment Study on Clinical Efficacy of Profile 3D in MITRAL Valve Annuloplasty
— · Mitral Valve Insufficiency · Completed · est. 2017-04-26
Reveal® XT Performance Trial (XPECT)
— · Atrial Fibrillation, Risk of Cardiac Arrhythmias · Completed · est. 2008-08
MiniMed Fit Payload Wear Study
— · Diabetes (Insulin-requiring, Type 1 or Type 2) · Completed · est. 2026-05-14
Evaluation of PillCam™ Colon 2 in Visualization of the Colon
— · Colonic Diseases, Bowel Diseases · Completed · est. 2010-05
An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance
— · Diabetes · Completed · est. 2010-01
A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue
— · Non-emergent, Soft Tissue Procedures, Performed Via an Open Approach · Completed · est. 2013-05
Continued Access Protocol
— · Atrial Fibrillation · Completed · est. 2013-10
A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear)
— · Coronary Artery Disease · Completed · est. 2020-03-10
RESOLUTE China Registry:
— · Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases · Completed · est. 2013-04
A Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease
— · Degenerative Disc Disease · Completed · est. 2002-10
Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
— · Atrial Fibrillation, Hypertension · Completed · est. 2021-04-19
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
— · Heart Failure · Active Not Recruiting · est. 2027-07
OM2 Low Saturation Verification
— · Hypoxia · Completed · est. 2025-02-27
Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.
— · Peripheral Arterial Disease · Completed · est. 2007-07
Post-Myocardial Infarction Remodeling Prevention Therapy
— · Acute Myocardial Infarction, Pacing Therapy, Cardiac Remodeling · Completed · est. 2015-10
MDT-1118 Japan DT Study
— · Heart Failure · Completed · est. 2020-12-30
Evaluation of PillCam™ Colon 2 in Visualization of the Colon
— · Colonic Diseases, and Large Bowel Diseases · Completed · est. 2010-09
Outpatient Study to Evaluate Safety and Effectiveness of the Low Glucose Suspend Feature
— · Type 1 Diabetes · Completed · est. 2013-06
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Medtronic is lead sponsor; 68 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 4252026-10-09425
- 4252026-10-08425
- SC TO-I/A2026-10-08SC TO-I/A
- 4252026-10-08425
- 4252026-10-08425
- 4252026-10-07425
- 4252026-10-06425
- 4252026-10-05425
- 4252026-10-02425
- 4252026-10-01425
- 4252026-09-30425
- 4252026-09-29425
- 4252026-09-28425
- 4252026-09-25425
- 4252026-09-25425
- 4252026-09-24425
- 4252026-09-23425
- 4252026-09-22425
- 4252026-09-21425
- 4252026-09-21425
- 4252026-09-21425
- 4252026-09-18425
- 4252026-09-17425
- SC TO-I/A2026-09-17SC TO-I/A
- 4252026-09-17425
- 8-K2026-09-17Current report (material event)
- 4252026-09-16425
- 4252026-09-16425
- 4252026-09-15425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
- 4252026-09-14425
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.